Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,249,203
-
Total 13F shares
-
1,310,290
-
Share change
-
-694,983
-
Total reported value
-
$9,986,632
-
Put/Call ratio
-
2%
-
Price per share
-
$7.62
-
Number of holders
-
33
-
Value change
-
-$5,421,678
-
Number of buys
-
12
-
Number of sells
-
25
Institutional Holders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) as of Q1 2021
As of 31 Mar 2021,
Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,310,290 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, SILVERARC CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, FIRST TRUST ADVISORS LP, BLAIR WILLIAM & CO/IL, and NORTHERN TRUST CORP.
This page lists
33
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.